March 11-12, 2019
London, UK
We’ve invited the top most influential speakers from around the world to give inspirational talks and lead practical workshops.
Dr. Steven Todd Osterhout
The founder and director of Vitality Healthcare, an integrative medical and natural healing center catering to identifying the underlying causes of poor health with remarkable positive patient outcomes. USA
Prof. Dr. Ignat Ignatov
The Bulgarian scientist is involved in research projects for the study of biophysical and medical effects in the application of methodics for the influencing of human health. From 2007 Ignatov is honorable doctor in European Academy of Natural Sciences (Germany). Bulgaria
Prof. Christos Drossinakis
The Greek scientist is involved in research projects for the study of biophysical and medical effects in the application of methodics for the influencing of human health. Greece/Germany Bulgaria
Pulsus Group invites all the participants from all over the world to attend "8th World Congress on Immunology" (Immunology World 2019) on March 11-12, 2019 at London, UK. Conference includes prompt keynote presentations, Workshops, Oral talks, Poster presentations and Exhibitions.
Immunology conferences will gather people from academia, business and societies interested in immunology to share the latest trends and important issues relevant to immunology & related fields. Immunology World 2019 will provide the platform to meet global leaders in Immunology and relevant fields to hear their research at this exclusive scientific program. The Immunology Conference hosting presentations from editorial board members of prominent refereed journals, renowned and active investigators and decision makers in the field of Immunology. Immunology World 2019 Organizing Committee also invites Young investigators at every career stage to submit abstracts reporting their latest scientific findings in oral and poster sessions.
Why to Attend???
Immunology conferences are leading annual immunology conferences happening around the world. Immunology World 2019, the two days of the congress will host 50 Scientific and technical sessions on cutting edge research and latest research innovations in the field of Immunology and biomedical sciences across the globe.
The attendees can find
Session 1: Immune system
The immune system is the body's defence against infectious organisms and other invaders. Through a series of steps called the immune response, the immune system attacks organisms and substances that invade body systems and cause disease.
The immune system is made up of a network of cells, tissues, and organs that work together to protect the body. One of the important cells involved are white blood cells, also called leukocytes, which come in two basic types that combine to seek out and destroy disease-causing organisms or substances.
It is a defence mechanism by a human body that resist the entry of harmful microorganism to enter the body and even it prevents the growth of a similar microorganism in human body It is a process of detection and elimination of pathogens and harmful microorganism by the human body
Immune system involves cells and organs helps in the detection of self and non-self tissues and cells the immune system has evolved to protect the host from a universe of pathogenic microbes that are themselves constantly evolving. The immune system also helps the host eliminate toxic or allergenic
Related Conferences:
Vaccine and immunology November 22-23, 2018 Bucharest Romania, Vaccines and vaccinations June 3-4, 2019 London UK, Immunology and haematology and molecular biology December 5-6, 2018 Portugal Lisbon, 10th molecular immunology & immunogenetics congress March 4-5, 2019 Barcelona Spain, Allergy asthma & clinical immunology October 1-2, 2018 Moscow Russia
Related Associations
The American Association of Immunologists, CIS - CIS - Clinical Immunology Society, British Society for Immunology, European Federation of Immunological Societies, The Korean Association of Immunologists
Session 2: Immune response
The Immune response is the body's response caused by its immune system existence activated by antigens. The immune response can include immunity to pathogenic microorganisms and its products, as well as autoimmunity to self-antigens, allergies, and graft rejections. In this process, the main cells involved are T cells and B cells (subtypes of lymphocytes), and macrophages (a type of leukocyte or white blood cell). These cells produce lymphokines that influence the other host cells' activities. B cells mature to produce immunoglobulins (also known as antibodies), that react with antigens. At the similar time, macrophages process the antigens into immunogenic units which stimulate B lymphocytes to differentiate into antibody-secreting plasma cells, stimulating the T cells to release lymphokines
A compliment is a group of normal serum proteins that improve the immune response by fetching activated as the result of the antigen-antibody interaction. The first contact with any antigen sensitizes separate affected and promote the primary immune response. Next, of the sensitized individuals with the same antigen result in a more rapid and massive reaction, called the secondary immune response ("booster response" or the "anamnestic reaction"). It is most expressed in the level of circulating serum antibodies.
An anamnestic response in medicine is a delayed immunologic response. The term is frequently used in transfusion medicine and refers to a re-exposure incident where the antibody is formed on initial exposure to an antigen in a transfused unit, but the specific memory B cell population fades over time, with antibody becoming undetectable over years. If a patient is re-exposed to the same offending antigen in a future transfusion (which might happen because the antibody screen would, in fact, be negative), there would still be a massive, rapid production of IgG antibody against the antigen, which will predictably lyse the transfused red cells, a delayed hemolytic transfusion reaction
Related Conferences:
International immunology conference October 25-26,2018 Paris France, 12thInternational Conference on Allergy, Immunology & Rheumatology, Paris, France, February 21-23, 2019, Global Congress on Immunology & Vaccination, Chicago, USA, November 5-7, 2018, 11th Global Summit on Immunology and Cell Biology, March 18-19, 2019 Sydney, Australia, 2nd World Congress on Allergy, Infectious Diseases and Immunology, March 18-19, 2019 Sydney, Australia,
Related Associations
IUIS - International Union of Immunological Societies, Indian Immunology Society, The Federation of Clinical Immunology Societies, Australasian Society for Immunology, The American Academy of Allergy, Asthma & Immunologypopulation fades over time, with antibody becoming undetectable over years. If a patient is re-exposed to the same offending antigen in a future transfusion (which might happen because the antibody screen would, in fact, be negative), there would still be a massive, rapid production of IgG antibody against the antigen, which will predictably lyse the transfused red cells, a delayed hemolytic transfusion reaction
Related Conferences:
International immunology conference October 25-26,2018 Paris France, 12thInternational Conference on Allergy, Immunology & Rheumatology, Paris, France, February 21-23, 2019, Global Congress on Immunology & Vaccination, Chicago, USA, November 5-7, 2018, 11th Global Summit on Immunology and Cell Biology, March 18-19, 2019 Sydney, Australia, 2nd World Congress on Allergy, Infectious Diseases and Immunology, March 18-19, 2019 Sydney, Australia,
Related Associations
IUIS - International Union of Immunological Societies, Indian Immunology Society, The Federation of Clinical Immunology Societies, Australasian Society for Immunology, The American Academy of Allergy, Asthma & Immunology
Session 3: Immunity and infectious agents
Immunity is the capability of multicellular organisms to resist harmful & pathogenic microorganism from entering it. Immunity involves both specific and non-specific components. The non-specific components act as barriers or eliminators of a wide range of pathogens irrespective of their antigenic makeup. Other components of the immune system adapt themselves to each new disease encountered and can generate pathogen-specific immunity
Infectious agents are the microbial agents like virus, bacteria, fungi are the responsible for causing infections to the host cells by transmitting from one cell to another they even cause infectious diseases which are transmittable diseases or communicable diseases
Related Conferences:
7th International Conference on HIV/AIDS, STDs and STIs, March 18-19, 2019 New York, USA, 6th International Conference on Parasitology & Microbiology, July 29-30, 2019 Amsterdam, Netherlands, 11th Annual Congress on Immunology & Immuno technology, September 13-14, 2018 Zurich, Switzerland, Cold Spring Harbour Asia Conference: Frontiers of Immunology in Health & Disease, September 2018, 10–14, Suzhou, China, The London Infections & Immunity Symposium, November 2018 5–6, London, UK, Federation of Immunological Societies of Asia-Oceania (FIMSA)November 2018, 10–13, Bangkok, Thailand, , 3rd Innate Lymphoid Cell Meeting, November 29–1 December 2018, Tokyo, Japan
Sessions 4: Antibodies
An antibody (Ab), also known as an immunoglobulin (Ig) is a large, Y-shaped protein produced mostly by plasma cells that are used by the immune system to neutralize pathogens such as pathogenic bacteria and viruses. The antibody distinguishes a unique molecule of the pathogen, called an antigen, via the Fab's variable region Each tip of the "Y" of an antibody contains a paratope (analogous to a lock) that is exact for one epitope (similarly, analogous to a key) on an antigen, permitting these two structures to bind calm with precision. By means of this binding mechanism, an antibody can tag a microbe or an infected cell for attack by other parts of the immune system, or can neutralize its target directly (for example, by inhibiting a part of a microbe that is essential for its invasion and survival). Depending on the antigen, the binding may impede the biological process causing the disease or may activate macrophages to destroy the foreign substance. The ability of an antibody to communicate with the other components of the immune system is mediated via its Fc region (located at the base of the "Y"), which contains a conserved glycosylation site involved in these interactions. The production of antibodies is the main function of the humoral immune system.
Related Conferences:
Vaccine and immunology November 22-23, 2018 Bucharest Romania, Vaccines and vaccinations June 3-4, 2019 London UK, Immunology and haematology and molecular biology December 5-6, 2018 Portugal Lisbon, 10th molecular immunology & immunogenetics congress March 4-5, 2019 Barcelona Spain, Allergy asthma & clinical immunology October 1-2, 2018 Moscow Russia
Related Associations
The American Association of Immunologists, CIS - CIS - Clinical Immunology Society, British Society for Immunology, European Federation of Immunological Societies, The Korean Association of Immunologists
Related Associations
Federation of African immunological societies, The Canadian Society for Immunology, Latin American Association of Immunology, The Chinese Society for Immunology, Association for Cancer Immunotherapy, California Society of Allergy, Asthma and Immunology, Illinois Society of Allergy, Asthma and Immunology
Session 5: Vaccinology
The process of production and development of vaccines which consist of biological agents which are similar to disease-causing microorganisms in a weakened form it means that the pathogenicity is disintegrated from the microorganism
the vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine characteristically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, conclusion it, and to further recognize and destroy any of the microorganisms associated with that agent that it may encounter in the forthcoming. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by a natural or "wild" pathogen), or relaxing (e.g., vaccines against cancer are being investigated).
The management of vaccines is called vaccination. Vaccination is the most effective technique of preventing infectious diseases widespread immunity due to vaccination is largely accountable for the worldwide eradication of smallpox and the restriction of diseases such as polio, measles, and tetanus from much of the world. The efficiency of vaccination has been extensively studied and verified; for example, the influenza vaccine, the HPV vaccine, and the chicken poxhttps://immunology.cmesociety.com/ vaccine. The World Health Organization (WHO) reports that licensed vaccines are currently existing for twenty-five different preventable infections.
Related Conferences:
International immunology conference October 25-26,2018 Paris France, 12thInternational Conference on Allergy, Immunology & Rheumatology, Paris, France, February 21-23, 2019, Global Congress on Immunology & Vaccination, Chicago, USA, November 5-7, 2018, 11th Global Summit on Immunology and Cell Biology, March 18-19, 2019 Sydney, Australia, 2nd World Congress on Allergy, Infectious Diseases and Immunology, March 18-19, 2019 Sydney, Australia,
Related Associations
IUIS - International Union of Immunological Societies, Indian Immunology Society, The Federation of Clinical Immunology Societies, Australasian Society for Immunology, The American Academy of Allergy, Asthma & Immunology
Session 6: Immunological assays
An immunoassay is a biochemical test that dealings the presence or concentration of a macromolecule or a small molecule in a solution by means of an antibody (usually) or an antigen (sometimes). The molecule detected by the immunoassay is often referred to as an "analyte" and is in many cases a protein, though it may be other kinds of molecules, of different size and types if the proper antibodies that have the adequate properties for the assay are developed. Analytes in biological liquids such as serum or urine are frequently measured using immunoassays for medical and research purposes.
Immunoassays come in numerous different formats and variations. Immunoassays may be run in multiple steps with reagents being added and washed away or separated at different points in the assay. Multi-step assays are often called separation immunoassays or heterogeneous immunoassays. Some immunoassays can be carried out simply by mixing the reagents and sample and making a physical measurement. Such assays are called homogenous immunoassays or less frequently non-separation immunoassays.
The use of a calibrator is often employed in immunoassays. Calibrators are solutions that are known to contain the analyte in question, and the concentration of that analyte is generally known. Comparison of an assay's response to a real sample against the assay's response produced by the calibrators makes it possible to interpret the signal strength in terms of the presence or concentration of an analyte in the sample.
Related Conferences:
7th International Conference on HIV/AIDS, STDs and STIs, March 18-19, 2019 New York, USA, 6th International Conference on Parasitology & Microbiology, July 29-30, 2019 Amsterdam, Netherlands, 11th Annual Congress on Immunology & Immune technology, September 13-14, 2018 Zurich, Switzerland, Cold Spring Harbour Asia Conference: Frontiers of Immunology in Health & Disease, September 2018, 10–14, Suzhou, China, The London Infections & Immunity Symposium, November 2018 5–6, London, UK, Federation of Immunological Societies of Asia-Oceania (FIMSA)November 2018, 10–13, Bangkok, Thailand, , 3rd Innate Lymphoid Cell Meeting, November 29–1 December 2018, Tokyo, Japan
Related Associations
Federation of African immunological societies, The Canadian Society for Immunology, Latin American Association of Immunology, The Chinese Society for Immunology, Association for Cancer Immunotherapy, California Society of Allergy, Asthma and Immunology, Illinois Society of Allergy, Asthma and Immunology
Session 7: Autoimmune disease
the process in which the immune system of the human body loses its ability to recognise self and non-self-tissues & organs it can be affected to any part of the body
Autoimmune diseases result from a dysfunction of the immune system. The immune system guards from disease and infection. Sometimes, however, the immune system can produce autoantibodies that attack healthy cells, tissues, and organs. This can principal to autoimmune disease.
Related Conferences:
Vaccine and immunology November 22-23, 2018 Bucharest Romania, Vaccines and vaccinations June 3-4, 2019 London UK, Immunology and haematology and molecular biology December 5-6, 2018 Portugal Lisbon, 10th molecular immunology & immunogenetics congress March 4-5, 2019 Barcelona Spain, Allergy asthma & clinical immunology October 1-2, 2018 Moscow Russia
Related Associations
The American Association of Immunologists, CIS - CIS - Clinical Immunology Society, British Society for Immunology, European Federation of Immunological Societies, The Korean Association of Immunologists
Session 8: Immunotherapy
Immunotherapy is the "treatment of disease by persuading, enhancing, or suppressing an immune response “Immunotherapies designed to elicit or amplify an immune response are underground as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.
In recent years, immunotherapy has become of great interest to researchers, clinicians and pharmaceutical companies, predominantly in its promise to treat various forms of cancer
Immunomodulatory regimens often have fewer side effects than existing drugs, as well as less potential for creating resistance when treating microbial disease.
Cell-based immunotherapies are actual for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells (NK Cell), cytotoxic T lymphocytes (CTL), etc., work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumour cells.
Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use. various chemokines, synthetic cytosine-phosphate-guanosine (CpG) oligodeoxynucleotides and glucans are involved in clinical and preclinical studies.
Related Conferences:
International immunology conference October 25-26,2018 Paris France, 12thInternational Conference on Allergy, Immunology & Rheumatology, Paris, France, February 21-23, 2019, Global Congress on Immunology & Vaccination, Chicago, USA, November 5-7, 2018, 11th Global Summit on Immunology and Cell Biology, March 18-19, 2019 Sydney, Australia, 2nd World Congress on Allergy, Infectious Diseases and Immunology, March 18-19, 2019 Sydney, Australia,
Related Associations
IUIS - International Union of Immunological Societies, Indian Immunology Society, The Federation of Clinical Immunology Societies, Australasian Society for Immunology, The American Academy of Allergy, Asthma & Immunology
Session 9: Immunogenetics
Immunogenetics is a subspecialty of medicine that studies the connection between genetics and immunology. Immunogenetics helps in sympathetic to the pathogenesis of several autoimmune and infectious diseases.
Autoimmune diseases, such as type 1 diabetes, stand complex genetic traits which result from defects in the immune system. Identification of genes defining the immune defects may identify new target genes for therapeutic approaches. On the other hand, genetic differences can also benefit to define the immunological pathway principal to disease.
Related Conferences:
7th International Conference on HIV/AIDS, STDs and STIs, March 18-19, 2019 New York, USA, 6th International Conference on Parasitology & Microbiology, July 29-30, 2019 Amsterdam, Netherlands, 11th Annual Congress on Immunology & Immuno technology, September 13-14, 2018 Zurich, Switzerland, Cold Spring Harbour Asia Conference: Frontiers of Immunology in Health & Disease, September 2018, 10–14, Suzhou, China, The London Infections & Immunity Symposium, November 2018 5–6, London, UK, Federation of Immunological Societies of Asia-Oceania (FIMSA)November 2018, 10–13, Bangkok, Thailand, , 3rd Innate Lymphoid Cell Meeting, November 29–1 December 2018, Tokyo, Japan
Related Associations
Federation of African immunological societies, The Canadian Society for Immunology, Latin American Association of Immunology, The Chinese Society for Immunology, Association for Cancer Immunotherapy, California Society of Allergy, Asthma and Immunology, Illinois Society of Allergy, Asthma and Immunology
Session 10: Immunoproteomics
Immunoproteomics becomes a potent methodology used for classifying immunoreactive proteins. In this study, an immunoproteomic method based on 2-dimensional gel electrophoresis (2D-PAGE) and immunoblotting mutual with high-resolution mass spectrometry (MS) was used to classify immunoreactive proteins that might be involved in mechanisms of Guillain-Barré syndrome (GBS) development, regardless of their possible reciprocal molecular mimicry. Proteins isolated from C. jejune and human peripheral nerve tissue (HPN) were separated with 2D SDS-PAGE and subjected to western blotting using serum samples from GBS patients. The peptides generated after proteolysis of the immunoreactive proteins acquiesced to nanoflow-high performance liquid chromatography-nano electrospray ionization coupled to high-resolution mass spectrometry (nHPLC-nESI-MS and MS/MS) followed by Sequestrated analysis for proteins identification. In C. jejuni, immunoreactivity was found for GroEL and DnaK, structural proteins (MOMP), key enzymatic proteins necessary for the microbial proliferation (adenylate kinase, enolase, inorganic pyrophosphatase and aspartate ammonia-lyase), and antioxidant enzymes (alkyl hydroperoxide reductase–AhpC and DNA protection during starvation protein - DNA protection factor against Fe2+-mediated oxidative stress).
Related Conferences:
Vaccine and immunology November 22-23, 2018 Bucharest Romania, Vaccines and vaccinations June 3-4, 2019 London UK, Immunology and haematology and molecular biology December 5-6, 2018 Portugal Lisbon, 10th molecular immunology & immunogenetics congress March 4-5, 2019 Barcelona Spain, Allergy asthma & clinical immunology October 1-2, 2018 Moscow Russia
Related Associations
The American Association of Immunologists, CIS - CIS - Clinical Immunology Society, British Society for Immunology, European Federation of Immunological Societies, The Korean Association of Immunologists
Session 11: Immunotolerance
immunotolerance is a state of the insensitivity of the immune system to substances or tissue that have the capacity to provoke an immune response in a specified organism. It is brought by prior exposure to that specific antigen then contrasts with the predictable immune-mediated elimination of foreign antigens. Tolerance is classified into central tolerance or peripheral tolerance depending on where the state is originally persuaded—in the thymus and bone marrow(central) or in other tissues and lymph nodes (peripheral). The mechanisms by which these forms of tolerance are established are distinct, but the subsequent effect is parallel.
Related Conferences:
Vaccine and immunology November 22-23, 2018 Bucharest Romania, Vaccines and vaccinations June 3-4, 2019 London UK, Immunology and haematology and molecular biology December 5-6, 2018 Portugal Lisbon, 10th molecular immunology & immunogenetics congress March 4-5, 2019 Barcelona Spain, Allergy asthma & clinical immunology October 1-2, 2018 Moscow Russia
Related Associations
The American Association of Immunologists, CIS - CIS - Clinical Immunology Society, British Society for Immunology , European Federation of Immunological Societies, The Korean Association of Immunologists
Session 12; Immunopathology
Immunopathology is a division of medicine that deals over immune responses related to the disease. It includes the study of the pathology of an organism, organ system, or disease with admiration to the immune system, immunity, and immune responses. In biology, it references to damage caused to an organism by its immune response, because of an infection. It could be due to a mismatch between pathogen and host species, and frequently occurs as soon as an animal pathogen infects a human
Related Conferences:
International immunology conference October 25-26,2018 Paris France, 12thInternational Conference on Allergy, Immunology & Rheumatology, Paris, France, February 21-23, 2019, Global Congress on Immunology & Vaccination, Chicago, USA, November 5-7, 2018, 11th Global Summit on Immunology and Cell Biology, March 18-19, 2019 Sydney, Australia, 2nd World Congress on Allergy, Infectious Diseases and Immunology, March 18-19, 2019 Sydney, Australia,
Related Associations
IUIS - International Union of Immunological Societies, Indian Immunology Society, The Federation of Clinical Immunology Societies, Australasian Society for Immunology, The American Academy of Allergy, Asthma & Immunology
Session 13: Immunotoxicology
The study of immune dysfunction consequential exposure of an organism to xenobiotics The immune dysfunction might take the form of immunosuppression or on the other hand, allergy, autoimmunity or any number of inflammatory-based diseases or pathologies. Since the immune system plays a dangerous role in host resistance to disease as well as in normal homeostasis of an organism, identification of immunotoxin risk is significant in the protection of human, animal and wildlife health.
Related Conferences:
7th International Conference on HIV/AIDS, STDs and STIs, March 18-19, 2019 New York, USA, 6th International Conference on Parasitology & Microbiology, July 29-30, 2019 Amsterdam, Netherlands, 11th Annual Congress on Immunology & Immuno technology, September 13-14, 2018 Zurich, Switzerland, Cold Spring Harbour Asia Conference: Frontiers of Immunology in Health & Disease, September 2018, 10–14, Suzhou, China, The London Infections & Immunity Symposium, November 2018 5–6, London, UK, Federation of Immunological Societies of Asia-Oceania (FIMSA)November 2018, 10–13, Bangkok, Thailand, , 3rd Innate Lymphoid Cell Meeting, November 29–1 December 2018, Tokyo, Japan
Related Associations
Federation of African immunological societies, The Canadian Society for Immunology, Latin American Association of Immunology, The Chinese Society for Immunology, Association for Cancer Immunotherapy, California Society of Allergy, Asthma and Immunology, Illinois Society of Allergy, Asthma and Immunology
Session 14: Microbiology & Parasitology
parasitology traditionally has included the study of three major groups of animals: parasitic protozoa, parasitic helminths (worms), and those arthropods that directly cause disease or performance as vectors of various pathogens. A parasite is a pathogen that concurrently injures and derives sustenance as of its host. Some organisms called parasites are commensals, in that they neither assistance nor harm their host (for example, Entamoeba coli). Granting parasitology had its origins in the zoologic sciences, it is today an interdisciplinary field, greatly influenced by microbiology, immunology, biochemistry, and other life sciences.
Related Conferences:
International immunology conference October 25-26,2018 Paris France, 12thInternational Conference on Allergy, Immunology & Rheumatology, Paris, France, February 21-23, 2019, Global Congress on Immunology & Vaccination, Chicago, USA, November 5-7, 2018, 11th Global Summit on Immunology and Cell Biology, March 18-19, 2019 Sydney, Australia, 2nd World Congress on Allergy, Infectious Diseases and Immunology, March 18-19, 2019 Sydney, Australia,
Related Associations
IUIS - International Union of Immunological Societies, Indian Immunology Society, The Federation of Clinical Immunology Societies, Australasian Society for Immunology, The American Academy of Allergy, Asthma & Immunology
Session 15: Allergies & hypersensitivity
Allergies, also recognized as allergic diseases, are a numeral of conditions caused by hypersensitivity of the immune system to classically harmless substances in the environment These diseases contain hay fever, food allergies, atopic dermatitis, allergic asthma, and anaphylaxis. Symptoms may embrace red eyes, an itchy rash, sneezing, a runny nose, shortness of breath, or swelling. Food intolerances and food poisoning are separate circumstances.
Related Conferences:
7th International Conference on HIV/AIDS, STDs and STIs, March 18-19, 2019 New York, USA, 6th International Conference on Parasitology & Microbiology, July 29-30, 2019 Amsterdam, Netherlands, 11th Annual Congress on Immunology & Immuno technology, September 13-14, 2018 Zurich, Switzerland, Cold Spring Harbour Asia Conference: Frontiers of Immunology in Health & Disease, September 2018, 10–14, Suzhou, China, The London Infections & Immunity Symposium, November 2018 5–6, London, UK, Federation of Immunological Societies of Asia-Oceania (FIMSA)November 2018, 10–13, Bangkok, Thailand, , 3rd Innate Lymphoid Cell Meeting, November 29–1 December 2018, Tokyo, Japan
Related Associations
Federation of African immunological societies, The Canadian Society for Immunology, Latin American Association of Immunology, The Chinese Society for Immunology, Association for Cancer Immunotherapy, California Society of Allergy, Asthma and Immunology, Illinois Society of Allergy, Asthma and Immunology
Session 16: Immune – oncology
The use of the immune system to treat cancer. Immunotherapies can be categorized as active, passive or hybrid (active and passive). These tactics exploit the fact that cancer cells repeatedly have molecules on their surface that can be noticed by the immune system, identified as tumour-associated antigens they are often proteins or other macromolecules (e.g. carbohydrates). Active immunotherapy directs the immune system to attack tumour cells by targeting TAAs. Passive immunotherapies enhance existing anti-tumour responses and comprise the use of monoclonal antibodies, lymphocytes and cytokines.
Related Conferences:
Vaccine and immunology November 22-23, 2018 Bucharest Romania, Vaccines and vaccinations June 3-4, 2019 London UK, Immunology and haematology and molecular biology December 5-6, 2018 Portugal Lisbon, 10th molecular immunology & immunogenetics congress March 4-5, 2019 Barcelona Spain, Allergy asthma & clinical immunology October 1-2, 2018 Moscow Russia
Related Associations
The American Association of Immunologists, CIS - CIS - Clinical Immunology Society, British Society for Immunology, European Federation of Immunological Societies, The Korean Association of Immunologists
Session 17: Transfusion immunology
It is the branch of medicine deals by the transfusion of blood and blood mechanisms and the laboratory tests similar immunohematology, blood donation test transfusion practices, patient blood management therapeutic apheresis, stem cell gatherings, cellular therapy, and coagulation. Laboratory management and understanding of state and federal regulations connected to blood products are likewise a large part of the field.
Related Conferences:
International immunology conference October 25-26,2018 Paris France, 12thInternational Conference on Allergy, Immunology & Rheumatology, Paris, France, February 21-23, 2019, Global Congress on Immunology & Vaccination, Chicago, USA, November 5-7, 2018, 11th Global Summit on Immunology and Cell Biology, March 18-19, 2019 Sydney, Australia, 2nd World Congress on Allergy, Infectious Diseases and Immunology, March 18-19, 2019 Sydney, Australia,
Related Associations
IUIS - International Union of Immunological Societies, Indian Immunology Society, The Federation of Clinical Immunology Societies, Australasian Society for Immunology, The American Academy of Allergy, Asthma & Immunology
Session 18: Clinical Immunology
Clinical immunology is the study of diseases caused by the disorders in the immune system like immunodeficiency where immune system loses its ability to provide an adequate response to the primary immune diseases, autoimmunity where again immune system fails in recognising self and non-self-cells of the immune system and the other prominent kind of disorder is hypersensitivity
Related Conferences:
7th International Conference on HIV/AIDS, STDs and STIs, March 18-19, 2019 New York, USA, 6th International Conference on Parasitology & Microbiology, July 29-30, 2019 Amsterdam, Netherlands, 11th Annual Congress on Immunology & Immuno technology, September 13-14, 2018 Zurich, Switzerland, Cold Spring Harbour Asia Conference: Frontiers of Immunology in Health & Disease, September 2018, 10–14, Suzhou, China, The London Infections & Immunity Symposium, November 2018 5–6, London, UK, Federation of Immunological Societies of Asia-Oceania (FIMSA)November 2018, 10–13, Bangkok, Thailand, , 3rd Innate Lymphoid Cell Meeting, November 29–1 December 2018, Tokyo, Japan
Related Associations
Federation of African immunological societies, The Canadian Society for Immunology, Latin American Association of Immunology, The Chinese Society for Immunology, Association for Cancer Immunotherapy, California Society of Allergy, Asthma and Immunology, Illinois Society of Allergy, Asthma and Immunology
Session 19: Computational immunology
it comprises of both genomics and bioinformatics approaches towards the immunology where the immunological problems are converted to computational data and they are resolved using mathematical and computational approaches and the result are in the immunologically meaningful interpretation and usage of Models and Tools covers the methodological framework and claim of cutting-edge tools and methods to study immunological processes
Related Conferences:
Vaccine and immunology November 22-23, 2018 Bucharest Romania, Vaccines and vaccinations June 3-4, 2019 London UK, Immunology and haematology and molecular biology December 5-6, 2018 Portugal Lisbon, 10th molecular immunology & immunogenetics congress March 4-5, 2019 Barcelona Spain, Allergy asthma & clinical immunology October 1-2, 2018 Moscow Russia
Related Associations
The American Association of Immunologists, CIS - CIS - Clinical Immunology Society, British Society for Immunology, European Federation of Immunological Societies, The Korean Association of Immunologists
Session 20: veterinary immunology
under the branch of biomedical, it is the study of disorders in the immune system of animals and it is even linked to the zoology and veterinary science, interested in how the immune system works, in what manner vaccines prevent disease and why vaccines sometimes do not work and cause contrary reactions. Cover both basic and applied features of immunology, this script explores the mechanisms of resistance to infectious disease, vaccines and immunologic diseases of domestic animals
Related Conferences:
International immunology conference October 25-26,2018 Paris France, 12thInternational Conference on Allergy, Immunology & Rheumatology, Paris, France, February 21-23, 2019, Global Congress on Immunology & Vaccination, Chicago, USA, November 5-7, 2018, 11th Global Summit on Immunology and Cell Biology, March 18-19, 2019 Sydney, Australia, 2nd World Congress on Allergy, Infectious Diseases and Immunology, March 18-19, 2019 Sydney, Australia,
Related Associations
IUIS - International Union of Immunological Societies, Indian Immunology Society, The Federation of Clinical Immunology Societies, Australasian Society for Immunology, The American Academy of Allergy, Asthma & Immunology
Session 21: Ocular Immunology
Ocular Immunology is sympathetic of the immune response to various allergies, inflammation and infections of ocular tissue including retina and uveitis. Ocular Immunology developed highly specialized diagnostic and therapeutic skills in gentle for patients with destructive inflammatory diseases of the eye interceded by abnormal immunoregulatory processes.
Related Conferences:
7th International Conference on HIV/AIDS, STDs and STIs, March 18-19, 2019 New York, USA, 6th International Conference on Parasitology & Microbiology, July 29-30, 2019 Amsterdam, Netherlands, 11th Annual Congress on Immunology & Immuno technology, September 13-14, 2018 Zurich, Switzerland, Cold Spring Harbour Asia Conference: Frontiers of Immunology in Health & Disease, September 2018, 10–14, Suzhou, China, The London Infections & Immunity Symposium, November 2018 5–6, London, UK, Federation of Immunological Societies of Asia-Oceania (FIMSA)November 2018, 10–13, Bangkok, Thailand, , 3rd Innate Lymphoid Cell Meeting, November 29–1 December 2018, Tokyo, Japan
Related Associations
Federation of African immunological societies, The Canadian Society for Immunology, Latin American Association of Immunology, The Chinese Society for Immunology, Association for Cancer Immunotherapy, California Society of Allergy, Asthma and Immunology, Illinois Society of Allergy, Asthma and Immunology
Session 22: Reproductive Immunology
Field of medicine which deals with the refers to a field of medicine that studies interactions (or the absence of them) among the immune system and components connected to the reproductive system, such as maternal immune tolerance towards the fetus, or immunological interactions across the blood-testis barrier. The perception has been used by fertility clinics to explain the fertility problems, recurrent miscarriages and pregnancy complications experiential when this state of immunological tolerance is not successfully achieved. Immunological therapy is the new up and coming method for treating numerous cases of previously "mysterious infertility" or recurrent miscarriage.
Related Conferences:
Vaccine and immunology November 22-23, 2018 Bucharest Romania, Vaccines and vaccinations June 3-4, 2019 London UK, Immunology and haematology and molecular biology December 5-6, 2018 Portugal Lisbon, 10th molecular immunology & immunogenetics congress March 4-5, 2019 Barcelona Spain, Allergy asthma & clinical immunology October 1-2, 2018 Moscow Russia
Related Associations
The American Association of Immunologists, CIS - CIS - Clinical Immunology Society, British Society for Immunology , European Federation of Immunological Societies, The Korean Association of Immunologists
Session 23: Paediatrics immunology
Paediatric allergists/immunologists treat children since birth through the teenage years. They're high-quality to specialize in paediatrics allergy and immunology equips them to deliver the most experience in commerce with the unique medical needs of children who have allergies and immune system complications
Related Conferences:
International immunology conference October 25-26,2018 Paris France, 12thInternational Conference on Allergy, Immunology & Rheumatology, Paris, France, February 21-23, 2019, Global Congress on Immunology & Vaccination, Chicago, USA, November 5-7, 2018, 11th Global Summit on Immunology and Cell Biology, March 18-19, 2019 Sydney, Australia, 2nd World Congress on Allergy, Infectious Diseases and Immunology, March 18-19, 2019 Sydney, Australia,
Related Associations
IUIS - International Union of Immunological Societies, Indian Immunology Society, The Federation of Clinical Immunology Societies, Australasian Society for Immunology, The American Academy of Allergy, Asthma & Immunology
Session 24: System immunology
Systems immunology is a new research field that, under the greater umbrella of systems biology, aims to study the immune system in the more integrated perspective on how entities and players participate at different system levels to the immune function.
The immune system has been thoroughly analysed about to its components and function by using a very successful "reductionist" approach, but its overall functioning principles cannot easily be forecast by studying the properties of its isolated components because they strongly rely on and arise from the interactions among these numerous constituents. Systems immunology represents a different tactic for the integrated comprehension of the immune system structure and function based on complex systems theory, high-throughput techniques, as well as on mathematical and computational tools.
Related Conferences:
7th International Conference on HIV/AIDS, STDs and STIs, March 18-19, 2019 New York, USA, 6th International Conference on Parasitology & Microbiology, July 29-30, 2019 Amsterdam, Netherlands, 11th Annual Congress on Immunology & Immuno technology, September 13-14, 2018 Zurich, Switzerland, Cold Spring Harbour Asia Conference: Frontiers of Immunology in Health & Disease, September 2018, 10–14, Suzhou, China, The London Infections & Immunity Symposium, November 2018 5–6, London, UK, Federation of Immunological Societies of Asia-Oceania (FIMSA)November 2018, 10–13, Bangkok, Thailand, , 3rd Innate Lymphoid Cell Meeting, November 29–1 December 2018, Tokyo, Japan
Related Associations
Federation of African immunological societies, The Canadian Society for Immunology, Latin American Association of Immunology, The Chinese Society for Immunology, Association for Cancer Immunotherapy, California Society of Allergy, Asthma and Immunology, Illinois Society of Allergy, Asthma and Immunology
What is immunology?
In the process of evolution, the body of organisms has developed the property of distinguishing “self” and “nonself”, the “self” is accepted and “nonself” is rejected or degraded. For the rejection or degradation of “nonself”, organisms’ body has evolved a remarkably versatile defence system called immune system that operates via various mechanisms, which are collectively grouped under the name immunity or resistance (defence).
The immunity or resistance (defence) is, therefore, the insusceptibility of the body to the effect of “nonself’ factors like pathogenic microorganisms and their toxins and other kinds of foreign substances. The Latin term immunises, meaning “exempt” is the source of the term immunity, the English world. The branch of biology that deals with immunity or resistance are called immunology.
The immunity operation by the immune system of an organism’s body against the “nonself” is called an immune response, which can be considered to perform two interrelated functions: recognition and response. Recognition is highly specific and distinguishes one foreign pathogen from the other.
Immunology got recognition as a science in 1880 when the world witnessed a spate of progress brought about by the work of Louis Pasteur, who was studying with cholera bacterium, Pasteur had succeeded in culturing this bacterium and had shown that chickens developed cholera when the cultured bacteria were injected into them.
Importance & Scope:
The infectious immunology market is segmented based on types of diseases into HIV, hepatitis, pneumonia, tuberculosis, malaria, inflammatory bowel diseases and autoimmune diseases. Approximately 5,00,000 deaths are estimated to be caused by rotavirus infection. HBV affected nearly 1.9 million in the U.S. in 2013. According to the journal published by BioMed Central, rotavirus infection the leading cause of severe dehydrating diarrhoea among children worldwide. Every year rotavirus infection causes an estimated 111 million diarrhoea episodes leading to 2 million hospitalization cases and 400,000 deaths of children under 5 years.
Therapeutics Market: Key Players
AbbVie
Johnson & Johnson
Amgen
Genentech/Roche
Astellas
UCB
Eli Lilly
Sanofi
AstraZeneca
Novartis
Immunology got recognition as a science in 1880 when the world witnessed a spate of progress brought about by the work of Louis Pasteur, who was studying with cholera bacterium, Pasteur had succeeded in culturing this bacterium and had shown that chickens developed cholera when the cultured bacteria were injected into them.
Once he used an old culture for injection into some chickens, which fell ill but, to Pasteur’s surprise, they recovered. He subsequently injected these chickens again with freshly cultured bacteria, but these chickens were protected from cholera.
Pasteur speculated that ageing had weakened the virulence of the cholera bacterium and that such attenuated pathogens could be used for inoculation. Pasteur used the term “vaccine” for the attenuated strain in recognition of the work of Jenner with cowpox; the term “vaccine” is derived from the Latin world ‘vacca, meaning “cow”.
Pasteur’s experiment with the cholera bacterium represents a case of serendipity, which so often happens in science. In fact, Pasteur did not plan the above experiment, but he had to use the ‘old’ bacterial culture because he had been away on summer vacation, and he had to reinoculate the same chickens because his supply of fresh chickens was limited.
But this does not lessen the contribution of Pasteur; it only highlights as to how a genius exploits a chance observation to the best possible extent. Subsequently, Pasteur extended these findings to other diseases like anthrax disease of sheep; he vaccinated sheep with heat-attenuated anthrax bacillus (Bacillus anthracis).
In 1885, Pasteur administered a series of attenuated rabies virus preparations to a boy, Joseph Meister, who was repeatedly beaten by a mad dog. The boy survived and later became the custodian of Pasteur Institute. The latter was established in 1888 and became the professional centre for work in immunology.
Advantages of immunology conference :
Discuss emerging issues in Immunology, Molecular Biology
Discuss and apply recent research findings related to Molecular Immunology
Reflect on the place of critical developments, research ethics & challenges in Immunology
Market analysis
The market is expected to experience continued growth, from $61.5 billion in 2015 to $74.2 billion in 2022, at a compound annual growth rate of 2.71%. Immunology Market to 2022: From $61.5 Billion in 2015 to $74.2 Billion - Large Pipeline and Competitive Market to Drive Long-Term Market Growth. Global Immunology Market to 2022 is the Large pipeline and competitive market to drive long-term market growth the irresistible immunology market is sectioned in view of the sorts of items utilized for treatment, for example, indicative units, instruments and reagents. the foremost cause of severe dehydrating diarrhoea among children worldwide. Every year rotavirus infection causes a predictable 111 million diarrhoea episodes leading to 2 million hospitalization cases and 400,000 deaths of children under 5 years.
The worldwide clinical immunology market is anticipated to achieve USD 5.77 Billion by 2021 from USD 3.35 Billion in 2016, developing at a CAGR of 11.5% from 2016 to 2021. Showcase development can be official to variables, for example, the mechanical headways; rising rate of irresistible illnesses and developing flare-up of plagues; emerging medicinal services feeding over the world; and expanding financing, inquire about gifts, and open private interests in the field of life science explores.
It is expected that antibacterial usage will decrease slightly in developed countries because of an increasing pressure to combat antimicrobial resistance (AMR). Despite this, the antibacterial drug market is forecasted to grow from USD27.7 Billion in 2017 to USD35.6 Billion in 2022, at a compound annual growth rate (CAGR) of 3.97%.
Revenue from molecular immunology
The Global revenues for Molecular Immunology market are estimated at $62.57 billion in 2016 and are expected to reach $160.24 billion by 2023 growing at a CAGR of 14.3% from 2016 to 2023.
The North America Molecular Immunology Market was worth $28.52 Billion in 2016 and estimated to reach $50.71 Billion by the end of 2023 with a growing potential of 12.20 %.
The Europe Molecular Immunology Market was worth $13.02 Billion in 2016 and estimated to reach $23.41 Billion by the end of 2023 with a growing potential of 12.45 %.
Asia Pacific Molecular Immunology market is expecting a sound growth of CAGR of 15.5% during the forecasted period 2017-2023.
The LAMEA (Latin America, Middle East & Africa) Molecular Immunology Market is expecting a sound growth of 17.9% CAGR during the forecast period (2017 – 2023).
counted for $43.59 billion in 2016 and is estimated to reach $141.70 billion by 2026. The market is expected to grow at a compound annual growth rate (CAGR) of 11.23% between the years 2017 and 2026.
The above graph depicts that the growth of immunology market in different continents where the immunology contributes towards the economic growth of the different continents in North America the growth is approximately $40 billionsWhere as in Europe its $27 billions in the Asia Pacific region the revenue is around $21 billions Reaming rest of the world is $13billion
|
|
The global monoclonal antibodies (mAbs) market accounted for USD 85.4 billion in 2015 and is expected to exhibit a growth rate of 5.7% over the forecast period. Rising incidence of cancer and other chronic diseases is engendering the high demand for biologics, which is serving as the key contributing factor for the growth of monoclonal antibodies industry.
The graph has exponentially increased in market of monoclonal antibodies where humanizes antibodies expected growth from $20 billion to $39 billion in the year duration of 2013 to 2024, Similarly, with the chimeric antibodies expected growth from $65 billion to $80 billion in the duration of 2013 to 2024 And in the murine antibody sector from$80 billion to the expected growth to $120 billion in the duration of 2013 to 2024
